Evidence map›Paper›PMID 42080593›Full record

ArticleSchizophrenia bulletin2026

Childhood Adversities and Psychosis Across Populations: Insights From the 6-Country EU-GEI Study.

Craig Morgan, Charlotte Gayer-Anderson, Lucia Sideli, Hannah E Jongsma, Eva Velthorst, Ilaria Tarricone, Laura Ferraro, Daniele La Barbera, Caterina La Cascia, Antonio Lasalvia and 21 more

Abstract readMulticenter Study
In one paragraph

Article in Schizophrenia bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Craig MorganInstitute of Psychiatry, Psychology & Neuroscience, King's College London, London, SE5 8AB, United Kingdom.ORCID 0000-0002-3731-4930
Charlotte Gayer-AndersonInstitute of Psychiatry, Psychology & Neuroscience, King's College London, London, SE5 8AB, United Kingdom.ORCID 0000-0003-1636-889X
Lucia SideliDepartment of Human Science, LUMSA University, 00193 Rome, Italy.
Hannah E JongsmaDepartment of Psychiatry, University of Cambridge, Cambridge, CB2 2QQ, United Kingdom.
Eva VelthorstDepartmentof Community Mental Health, GGZ Noord-Holland-Noord, 1850 BA, Heerhugowaard, the Netherlands.ORCID 0000-0002-9240-2909
Ilaria TarriconeDepartment of Medical and Surgical Sciences, Alma Mater Studiorum, Bologna University, 40126 Bologna, Italy.
Laura FerraroDepartment of Biomedicine, Neuroscience, and Advanced Diagnostic, University of Palermo, 90133 Palermo, Italy.ORCID 0000-0002-1205-2356
Daniele La BarberaDepartment of Biomedicine, Neuroscience, and Advanced Diagnostic, University of Palermo, 90133 Palermo, Italy.
Caterina La CasciaDepartment of Biomedicine, Neuroscience, and Advanced Diagnostic, University of Palermo, 90133 Palermo, Italy.
Antonio LasalviaSection of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, 37134 Verona, Italy.ORCID 0000-0001-9963-6081
Sarah TosatoSection of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, 37134 Verona, Italy.ORCID 0000-0002-9665-7538
Domenico BerardiDepartment of Biomedical and NeuroMotor Sciences, Psychiatry Unit, Alma Mater Studiorum Università di Bologna, 40126 Bologna, Italy.
Celso ArangoInstitute of Psychiatry and Mental Health, Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, ISGM, CIBERSAM, 28007 Madrid, Spain.
Manuel ArrojoDepartment of Psychiatry, Psychiatric Genetic Group, Instituto de Investigación Sanitaria de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago de Compostela, 15706 Santiago, Spain.
Miguel BernardoBarcelona Clinic Schizophrenia Unit, Hospital Clinic de Barcelona, Institul d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona, 08017 Barcelona, Spain.ORCID 0000-0001-8748-6717
Julio BobesDepartment of Medicine, Psychiatry Area, School of Medicine, Universidad de Oviedo, ISPA, INEUROPA, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), 33011 Oviedo, Spain.
Julio SanjuánDepartment of Psychiatry, School of Medicine, Universidad de Valencia, Centro de Investigación Biomédica en Red de Salud Mental, 46010 Valencia, Spain.
Jose Luis SantosDepartment of Psychiatry, Hospital "Virgen de la Luz", 16003 Cuenca, Spain.
Paulo Menezes RossiDepartment of Preventive Medicine, Faculdade de Medicina, Universidade de São Paulo, São Paulo, 01246-903, Brazil.
Cristina Marta Del-BenDivision of Psychiatry, Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, Universidade de São Paulo, Ribeirão Preto - SP, 14051-140, Brazil.
Pierre-Michel LlorcaUniversité Clermont Auvergne, 63000 Clermont-Ferrand, France.
Andrea TortelliEstablissement Public de Santé, Maison Blanche, 75020 Paris, France.
Andre SzokeUniv Paris Est Creteil, INSERM, IMRB, AP-HP, Hôpitaux Universitaires « H. Mondor », DMU IMPACT, Fondation Fondamental, F-94010 Creteil, France.
Lieuwe de HaanDepartmentof Community Mental Health, GGZ Noord-Holland-Noord, 1850 BA, Heerhugowaard, the Netherlands.
Jean-Paul SeltenInstitute for Mental Health, GGZ Rivierduinen, 2333 ZZ, Leiden, The Netherlands.
Jim Van OsESRC Centre for Society and Mental Health, King's College London, London, SE5 8AB, United Kingdom.
Bart P RuttenDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, 6229 ER, Maastricht, The Netherlands.
Marta Di FortiESRC Centre for Society and Mental Health, King's College London, London, SE5 8AB, United Kingdom.
Peter B JonesDepartment of Psychiatry, University of Cambridge, Cambridge, CB2 2QQ, United Kingdom.ORCID 0000-0002-0387-880X
James B KirkbridePsyLife Group, Division of Psychiatry, University College London, London, W1T 7AD, United Kingdom.ORCID 0000-0003-3401-0824
Robin M MurrayESRC Centre for Society and Mental Health, King's College London, London, SE5 8AB, United Kingdom.

Funding

European Community's Seventh Framework Programme HEALTH-F2-2010-241909São Paulo Research Foundation 2012/0417-0UK Economic and Social Research Council ES/S012567/1UK Economic and Social Research Council UKRI861
6 · The paper itself

Abstract

background and hypothesisUsing data from the EU-GEI Work Package 2 (EU-GEI WP2) programme, we sought to test several hypotheses related to gaps in our knowledge of associations between childhood adversities and psychosis. STUDY

designEU-GEI WP2 comprises incidence and case-control studies of first-episode psychosis conducted in 17 sites in 6 countries. In each site, over 2-year periods, we identified and collected relevant data from individuals aged 18-64 with a first-episode psychosis and with no history of psychosis. Missing data were imputed. We used multi-level logistic regression to test our hypotheses. STUDY

resultsIn total, 1071 cases and 1497 controls were included. We found variations in the prevalence and the magnitude of associations between any adversity and psychosis by place (eg, odds ratios ranged from 0.4 [Cuenca, Spain] to 12.1 [Madrid, Spain]). The weighted percentages reporting adversities in control samples were associated with site incidence rates (eg, 3+ adversities: Spearman's rho 0.56, P .025). We found variations in the magnitude of associations by sex (eg, effect of physical and sexual abuse stronger among women), by age of exposure, and by severity and frequency of adversities (eg, largest odds ratios for adversities involving hostility, threat, and violence).

conclusionsVariations across populations in prevalence and effects of adversities may contribute to variations in rates of psychosis. Variations in effects by sex and age of onset may point to sex-specific mechanisms and to developmentally sensitive periods. Adversities involving severe threat, hostility, and violence may have the largest effects on risk of psychosis.

Indexed as

Adult Survivors of Child Adverse EventsAdverse Childhood ExperiencesPsychotic DisordersAdolescentAdultCase-Control StudiesEuropeFemaleHumansIncidenceMaleMiddle AgedPrevalenceYoung Adultclusters of adversityhostilitypopulation ratesthreatviolence

Identifiers

PMID42080593
PMCPMC13137326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.